Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
NCT ID: NCT06584630
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
80 participants
OBSERVATIONAL
2022-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis
NCT06206083
Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification
NCT07006103
Predictors of Node Positivity in Endometrial Cancer
NCT05793333
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
endometrial cancer patients that underwent molecular classification
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgical treatment at our Gynecological - Oncology Unit.
Exclusion Criteria
* Presence of a synchronous neoplasm.
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dimitrios Zouzoulas
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
1st Department of Obstetrics & Gynecology, AUTh, "Papageorgiou" Hospital
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
37577
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.